DE3040968C2 - Verfahren zur Herstellung von 3`-Desoxykanamycin A und hierbei eingesetztes Zwischenprodukt - Google Patents
Verfahren zur Herstellung von 3`-Desoxykanamycin A und hierbei eingesetztes ZwischenproduktInfo
- Publication number
- DE3040968C2 DE3040968C2 DE3040968A DE3040968A DE3040968C2 DE 3040968 C2 DE3040968 C2 DE 3040968C2 DE 3040968 A DE3040968 A DE 3040968A DE 3040968 A DE3040968 A DE 3040968A DE 3040968 C2 DE3040968 C2 DE 3040968C2
- Authority
- DE
- Germany
- Prior art keywords
- kanamycin
- deoxykanamycin
- isopropylidene
- cyclohexylidene
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 33
- 239000013067 intermediate product Substances 0.000 title description 2
- 238000004519 manufacturing process Methods 0.000 title description 2
- 229960000318 kanamycin Drugs 0.000 claims description 33
- 229930182823 kanamycin A Natural products 0.000 claims description 25
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 12
- 229930027917 kanamycin Natural products 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 8
- -1 imidazolylthiocarbonyl Chemical group 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000011445 neoadjuvant hormone therapy Methods 0.000 claims description 7
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 5
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 125000006239 protecting group Chemical group 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000011114 ammonium hydroxide Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000006392 deoxygenation reaction Methods 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960001192 bekanamycin Drugs 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 229930182824 kanamycin B Chemical group 0.000 description 4
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical group N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 description 4
- SYJXFKPQNSDJLI-HKEUSBCWSA-N neamine Chemical group N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](N)C[C@@H]1N SYJXFKPQNSDJLI-HKEUSBCWSA-N 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000005694 sulfonylation reaction Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000006103 sulfonylation Effects 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 2
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930190553 ribostamycin Chemical group 0.000 description 2
- 229960003485 ribostamycin Drugs 0.000 description 2
- NSKGQURZWSPSBC-NLZFXWNVSA-N ribostamycin Chemical group N[C@H]1[C@H](O)[C@@H](O)[C@H](CN)O[C@@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](CO)O2)O)[C@H](O)[C@@H](N)C[C@H]1N NSKGQURZWSPSBC-NLZFXWNVSA-N 0.000 description 2
- NSKGQURZWSPSBC-UHFFFAOYSA-N ribostamycin A Chemical group NC1C(O)C(O)C(CN)OC1OC1C(OC2C(C(O)C(CO)O2)O)C(O)C(N)CC1N NSKGQURZWSPSBC-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000003635 deoxygenating effect Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13979879A JPS5668698A (en) | 1979-10-31 | 1979-10-31 | New preparation of 3'-deoxykanamycin a |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3040968A1 DE3040968A1 (de) | 1981-05-14 |
DE3040968C2 true DE3040968C2 (de) | 1982-12-02 |
Family
ID=15253666
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3040968A Expired DE3040968C2 (de) | 1979-10-31 | 1980-10-30 | Verfahren zur Herstellung von 3`-Desoxykanamycin A und hierbei eingesetztes Zwischenprodukt |
DE3050399A Expired DE3050399C2 (de) | 1979-10-31 | 1980-10-30 | Verfahren zur Herstellung von 3'-Desoxykanamycin A und hierbei eingesetzte Zwischenprodukte |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3050399A Expired DE3050399C2 (de) | 1979-10-31 | 1980-10-30 | Verfahren zur Herstellung von 3'-Desoxykanamycin A und hierbei eingesetzte Zwischenprodukte |
Country Status (6)
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6140297A (ja) * | 1984-08-02 | 1986-02-26 | Microbial Chem Res Found | 3′−フルオロ−3′−デオキシカナマイシンa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS507595B1 (US07202987-20070410-C00007.png) * | 1970-07-29 | 1975-03-27 | ||
US4078139A (en) * | 1975-07-31 | 1978-03-07 | Schering Corporation | Process for deoxygenating secondary alcohols |
US4195170A (en) * | 1975-12-09 | 1980-03-25 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 3',4'-Episulfido kanamycin B compounds |
JPS543043A (en) * | 1977-06-10 | 1979-01-11 | Meiji Seika Kaisha Ltd | Amino-glycoside antibiotics; 1-n-(omega-aminoalkanesulfonyl)derivatives and their preparation |
-
1979
- 1979-10-31 JP JP13979879A patent/JPS5668698A/ja active Granted
-
1980
- 1980-10-20 US US06/198,612 patent/US4357466A/en not_active Expired - Lifetime
- 1980-10-30 GB GB8127841A patent/GB2081718B/en not_active Expired
- 1980-10-30 FR FR8023653A patent/FR2468615A1/fr active Granted
- 1980-10-30 DE DE3040968A patent/DE3040968C2/de not_active Expired
- 1980-10-30 GB GB8035016A patent/GB2064518B/en not_active Expired
- 1980-10-30 DE DE3050399A patent/DE3050399C2/de not_active Expired
- 1980-10-31 IT IT09573/80A patent/IT1154881B/it active
- 1980-10-31 IT IT1980A09573A patent/IT8009573A1/it unknown
Also Published As
Publication number | Publication date |
---|---|
FR2468615B1 (US07202987-20070410-C00007.png) | 1983-07-08 |
FR2468615A1 (fr) | 1981-05-08 |
GB2081718B (en) | 1983-11-09 |
IT8009573A1 (it) | 1982-05-01 |
IT1154881B (it) | 1987-01-21 |
US4357466A (en) | 1982-11-02 |
IT8009573A0 (it) | 1980-10-31 |
GB2081718A (en) | 1982-02-24 |
DE3050399C2 (de) | 1983-08-25 |
DE3040968A1 (de) | 1981-05-14 |
JPS5668698A (en) | 1981-06-09 |
DE3050399A1 (US07202987-20070410-C00007.png) | 1982-09-16 |
GB2064518A (en) | 1981-06-17 |
JPS631953B2 (US07202987-20070410-C00007.png) | 1988-01-14 |
GB2064518B (en) | 1983-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2726712C2 (US07202987-20070410-C00007.png) | ||
DE2945010C2 (de) | Verfahren zur Herstellung von durch Schutzgruppen N-acylierten Aminoglycosiden | |
DE2555479A1 (de) | Verfahren zur herstellung von 3', 4'-alpha-epoxyneamin und verwandten aminoglykosidischen antibiotika sowie die so hergestellten verbindungen | |
EP0032591B1 (de) | Verfahren zur Herstellung von gereinigten Aminoglycosid-Antibiotika | |
DE2427096A1 (de) | 2-deoxystreptamin-aminoglycoside und verfahren zu ihrer herstellung | |
DE2432644A1 (de) | Derivate von desoxystreptamin enthaltenden aminoglykosid-antibiotikumderivaten und verfahren zu ihrer herstellung | |
DE2708008C3 (de) | Verfahren zur Herstellung von 1-N-substituierten Kanamycinen, zur 1-N-Substitution eingesetzte cyclische Urethane und Verfahren zu deren Herstellung | |
DE2655731C3 (de) | Verfahren zur Herstellung von 3', 4'-Didesoxykanamycin B | |
DE2515629B2 (de) | 2'-N-substituierte Paromomycine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE2724597C3 (de) | 3'-Desoxykanamycin C und 3\4'-Didesoxykanamycin C, deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel | |
DE2533985C2 (de) | Verfahren zur Herstellung von 3'-Desoxyneamin, kanamycin B, ribostamycin, -6'-N-methylkanamycin B und paromamin | |
DE2350203B2 (de) | Verfahren zur Herstellung von 1-N- [(S) -2-Hydroxy-4-amino- butyryl] -neamin, -3', 4'-didesoxyneamin,-ribostamycin oder -3',4' -didesoxyribostamycin | |
DE3040968C2 (de) | Verfahren zur Herstellung von 3`-Desoxykanamycin A und hierbei eingesetztes Zwischenprodukt | |
DE2618009A1 (de) | 1-n-(alpha-hydroxy-omega-aminoacyl)-derivate des 3'-deoxykanamycins a und verfahren zur herstellung derselben | |
DE2515630A1 (de) | Antibiotische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE3004178C2 (US07202987-20070410-C00007.png) | ||
DE3227178C2 (de) | 2'-Modifizierte Kanamycine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antibakterielle Mittel | |
DE3044970A1 (de) | 3',4'-dideoxyparomomycin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel | |
DE2825289A1 (de) | 1-n-(omega-aminoalkansulfonyl)-derivate von aminoglycosidischen antibiotika und verfahren zur herstellung derselben | |
DE2436694A1 (de) | Verfahren zur herstellung von 1-n(s)-alpha-hydroxy-omega-aminoacyl)-derivaten von 3',4'-dideoxyneamin oder 3', 4'-dideoxyribostamycin | |
DE3040611A1 (de) | Verfahren zur herstellung von tobramycin | |
DE2741431C3 (de) | l-N-(L-4-Amino-2-hydroxybutyryl)-3'-desoxykanamycin-C, l-N-(L-4-Amino-2hydroxybutyryl)-3',4'-didesoxykanamycin-C und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Zusammensetzungen | |
DE2756057A1 (de) | Verfahren zur herstellung von 3',4'-dideoxykanamycin b | |
AT371480B (de) | Verfahren zur herstellung von neuen kanamycin a derivaten | |
DE2720199A1 (de) | Neamin-derivate und verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 3050399 Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 3050399 |
|
D2 | Grant after examination | ||
AH | Division in |
Ref country code: DE Ref document number: 3050399 Format of ref document f/p: P |
|
8339 | Ceased/non-payment of the annual fee |